Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations
- 1 April 2002
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 16 (6) , 859-863
- https://doi.org/10.1097/00002030-200204120-00005
Abstract
To determine the relative sensitivities of glucose transporter isoforms to the protease inhibitor indinavir and to determine the kinetic mechanism of indinavir-mediated Glut4 isoform inhibition. The rate of 2-deoxyglucose uptake was measured in Xenopus laevis oocytes heterologously expressing mammalian Glut isoforms. 2-Deoxyglucose uptake was also measured in 3T3-L1 fibroblasts, 3T3-L1 adipocytes, and primary rat adipocytes. The sensitivity to inhibition by indinavir among the Glut isoforms as assayed in the X. laevis oocyte system was as follows in decreasing order: Glut4 ≫ Glut2 > Glut3 > Glut1 ≈ Glut8. 2-Deoxyglucose uptake measurements in insulin-stimulated primary rat adipocytes indicated a non-competitive mode of transport inhibition by indinavir under zero-trans conditions with a K I of 15 μM. Indinavir appears to be a relatively selective inhibitor of the Glut4 isoform. As the concentration required to significantly inhibit insulin-stimulated glucose uptake in primary rat adipocytes is well within the physiologic range achieved in therapy, we conclude that direct inhibition of Glut4 contributes to the insulin resistance observed in patients receiving this drug.Keywords
This publication has 16 references indexed in Scilit:
- Metabolic complications associated with antiretroviral therapyAntiviral Research, 2001
- Adverse metabolic consequences of HIV protease inhibitor therapy: the search for a central mechanismAmerican Journal of Physiology-Endocrinology and Metabolism, 2001
- The Mechanism of Insulin Resistance Caused by HIV Protease Inhibitor TherapyJournal of Biological Chemistry, 2000
- GLUTX1, a Novel Mammalian Glucose Transporter Expressed in the Central Nervous System and Insulin-sensitive TissuesJournal of Biological Chemistry, 2000
- Impaired Glucose Transport as a Cause of Decreased Insulin-Stimulated Muscle Glycogen Synthesis in Type 2 DiabetesNew England Journal of Medicine, 1999
- Structure, Function, and Regulation of the Mammalian Facilitative Glucose Transporter Gene FamilyAnnual Review of Nutrition, 1996
- Intracellular targeting of the insulin-regulatable glucose transporter (GLUT4) is isoform specific and independent of cell type.The Journal of cell biology, 1991
- Differential regulation of two distinct glucose transporter species expressed in 3T3-L1 adipocytes: effect of chronic insulin and tolbutamide treatment.Proceedings of the National Academy of Sciences, 1989
- The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDMDiabetes, 1988
- Cytochalasin B and the kinetics of inhibition of biological transport. A case of asymmetric binding to the glucose carrierBiochimica et Biophysica Acta (BBA) - Biomembranes, 1978